MedTrace Logo

A Patient-Centric Platform Trial for Precision Oncology

NCT03793088 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2023-02-03

No results posted yet for this study

Summary

XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and associated supportive care will be collected for analysis.

Conditions

Sponsors & Collaborators

  • Cancer Commons

    collaborator OTHER

  • Musella Foundation for Brain Tumor Research and Information, Inc.

    collaborator UNKNOWN

  • Pediatric Oncology Experimental Therapeutics Investigators Consortium

    collaborator UNKNOWN

  • xCures

    lead INDUSTRY

Principal Investigators

  • Mark Shapiro · xCures / Cancer Commons

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-07
Primary Completion
2024-01-31
Completion
2026-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03793088 on ClinicalTrials.gov